Exploring Minimal/Measurable Residual Disease (MRD)

Matthew Frank, MD, PhD
Lori Muffly, MD, MS

Join us as we speak to Dr. Lori Muffly and Dr. Matthew Frank from Stanford Medicine in Stanford, CA, about the recent advancements in testing for Minimal/Measurable Residual Disease (MRD). In this episode, we delve into what MRD is, which blood cancers testing is currently used on, and how we can utilize it to more accurately monitor patients and customize treatment. The doctors also share exciting possibilities on how MRD and other testing can benefit patients in the future.   

CLICK HERE to participate in our episode survey.

Mentioned on this episode:

Additional LLS Support Resources:

Support for this episode provided by Genentech, Inc. and Biogen.

Leave a Comment

Your email address will not be published. Required fields are marked *